Shanghai Clinical Cohort - Esophageal Cancer

A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.

Completed

Looking for future studies?

Key information

Conditions

Esophageal Cancer Digestive System Diseases Digestive System Neoplasms Esophageal Diseases Esophageal Neoplasms Esophagectomy Gastrointestinal Diseases Gastrointestinal Neoplasms Head and Neck Neoplasms Neoplasms Neoplasms by Site

Sex eligibility

All sexes

Study type

Observational

Primary location

Shanghai Chest Hospital

Shanghai, 20030, China

About this study

A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Received esophagectomy in these centers for esophageal cancer.

Exclusion criteria

No esophagectomy.

Treatment and study plan

Esophagectomy

Procedure

esophagectomy

Primary outcomes

Overal survival

Time frame: From the date of enrollment until the date of death or loss of follow-up, assessed up to 10 years. Follow-up is scheduled every 3 months in the first 2 years. Every 6 months from the 2nd to the 5th year. Then once a year. Until death or loss of follow.

Sponsors and collaborators

Lead sponsor

Shanghai Chest Hospital

Other

Collaborators

Changhai Hospital
Shanghai Cancer Hospital, China
Shanghai Zhongshan Hospital

Registry information

Official study title

Shanghai Clinical Cohort - Esophageal Cancer Cohort

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Dec 31, 2025
Registry last updated: Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting